Centre Publications

2022

Please click here for publications from previous years

Author(s) Title Year Citation
Sutton TC, Lamirande EW, Patel DR, Johnson KEE, Czako R, Ghedin E, Lee RTC, Maurer-Stroh S, Subbarao K Sequential Transmission of Influenza Viruses in Ferrets Does Not Enhance Infectivity and Does Not Predict Transmissibility in Humans 2022 mBio. Dec 20;13(6):e0254022 
PubMed link
doi: 10.1128/mbio.02540-22
Schwab LSU, Farrukee R, Eléouët JF, Rameix-Welti MA, Londrigan SL, Brooks AG, Hurt AC, Coch C, Zillinger T, Hartmann G, Reading PC Retinoic Acid-Inducible Gene I Activation Inhibits Human Respiratory Syncytial Virus Replication in Mammalian Cells and in Mouse and Ferret Models of Infection 2022 J Infect Dis. Dec 13;226(12):2079-2088 
PubMed link
doi: 10.1093/infdis/jiac295
Nazareth J, Barr I, Sullivan SG, Goss C, Pan D, Martin CA, Sahota A, Stephenson I, Tang JW, Pareek M Intra-season waning of immunity following the seasonal influenza vaccine in early and late vaccine recipients 2022 J Infect. Dec;85(6):e172-e174 
PubMed link
doi: 10.1016/j.jinf.2022.10.011
Chung YT, Kuan CY, Liao GR, Albrecht RA, Tseng YY, Hsu YC, Ou SC, Hsu WL A variant NS1 protein from H5N2 avian influenza virus suppresses PKR activation and promotes replication and virulence in mammals 2022 Emerg Microbes Infect. Dec;11(1):2291-2303 
PubMed link
doi: 10.1080/22221751.2022.2114853
Abrehart T, Suryadinata R, McCafferty C, Jacobson J, Ignjatovic V, Robinson P, Crawford NW, Monagle P, Subbarao K, Satzke C, Wurzel D Age-related differences in SARS-CoV-2 binding factors: An explanation for reduced susceptibility to severe COVID-19 among children? 2022 Paediatr Respir Rev. Dec;44:61-69 
PubMed link
doi: 10.1016/j.prrv.2022.01.008
Lee LYY, Suryadinata R, McCafferty C, Ignjatovic V, Purcell DFJ, Robinson P, Morton CJ, Parker MW, Anderson GP, Monagle P, Subbarao K, Neil JA Heparin Inhibits SARS-CoV-2 Replication in Human Nasal Epithelial Cells 2022 Viruses. Nov 24;14(12):2620 
PubMed link
doi: 10.3390/v14122620
Villalón-Letelier F, Farrukee R, Londrigan SL, Brooks AG, Reading PC Isoforms of Human MARCH1 Differ in Ability to Restrict Influenza A Viruses Due to Differences in Their N Terminal Cytoplasmic Domain 2022 Viruses. Nov 18;14(11):2549 
PubMed link
doi: 10.3390/v14112549
Pymm P, Redmond SJ, Dolezal O, Mordant F, Lopez E, Cooney JP, Davidson KC, Haycroft ER, Tan CW, Seneviratna R, Grimley SL, Purcell DFJ, Kent SJ, Wheatley AK, Wang LF, Leis A, Glukhova A, Pellegrini M, Chung AW, Subbarao K, Uldrich AP, Tham WH, Godfrey DI, Gherardin NA Biparatopic nanobodies targeting the receptor binding domain efficiently neutralize SARS-CoV-2 2022 iScience. Nov 18;25(11):105259 
PubMed link
doi: 10.1016/j.isci.2022.105259
Zheng MZM, Fritzlar S, Wang Z, Tan TK, Kedzierska K, Townsend A, Reading PC, Wakim LM Cutting Edge: High-Dose Live Attenuated Influenza Vaccines Elicit Pulmonary Tissue-Resident Memory CD8+ T Cells in the Face of Pre-Existing Humoral Immunity 2022 J Immunol. Nov 15;209(10):1832-1836 
PubMed link
doi: 10.4049/jimmunol.2200577
Sadarangani SP, Young BE, Lian W, Phua HP, Chen MI, Barr I, Yeo TW, Dalan R, Chow A DYNAMIC cohort study evaluating metabolic predictors of influenza vaccine immune response in older adults 2022 NPJ Vaccines. Nov 1;7(1):135 
PubMed link
doi: 10.1038/s41541-022-00548-z
Arah OA, Sullivan SG, Fell DB, Regan AK Analyzing Uncontrolled Confounding of the Perinatal Health Effects of Severe Acute Respiratory Syndrome Coronavirus 2 Infection During Pregnancy 2022 J Infect Dis. Nov 1;226(9):1678-1680 
PubMed link
doi: 10.1093/infdis/jiac194
George AM, Wille M, Wang J, Anderson K, Cohen S, Moselen J, Lee LYY, Suen WW, Bingham J, Dalziel AE, Whitney P, Stannard H, Hurt AC, Williams DT, Deng YM, Barr IG A novel and highly divergent Canine Distemper Virus lineage causing distemper in ferrets in Australia 2022 Virology. Nov;576:117-126 
PubMed link
doi: 10.1016/j.virol.2022.09.001
Baz M, Deshpande N, Mackenzie-Kludas C, Mordant F, Anderson D, Subbarao K SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in Mice 2022 Emerg Infect Dis. Nov;28(11):2352-2355 
PubMed link
doi: 10.3201/eid2811.220718
Vanslambrouck JM, Wilson SB, Tan KS, Groenewegen E, Rudraraju R, Neil J, Lawlor KT, Mah S, Scurr M, Howden SE, Subbarao K, Little MH Enhanced metanephric specification to functional proximal tubule enables toxicity screening and infectious disease modelling in kidney organoids 2022 Nat Commun. Oct 8;13(1):5943 
PubMed link
doi: 10.1038/s41467-022-33623-z
Stannard HL, Mifsud EJ, Wildum S, Brown SK, Koszalka P, Shishido T, Kojima S, Omoto S, Baba K, Kuhlbusch K, Hurt AC, Barr IG Assessing the fitness of a dual-antiviral drug resistant human influenza virus in the ferret model 2022 Commun Biol. Sep 28;5(1):1026 
PubMed link
doi: 10.1038/s42003-022-04005-4
O'Neill G, Aziz A, Kuba M, Brown SK, Lau H, Soppe S, Baz M, Peck H, Deng YM, Subbarao K, Barr IG Report on influenza viruses received and tested by the Melbourne WHO Collaborating Centre for Reference and Research on Influenza during 2020-2021 2022 Commun Dis Intell (2018). Sep 26;46 
PubMed link
doi: 10.33321/cdi.2022.46.63
Xiong W, Tsang TK, Perera RAPM, Leung NHL, Fang VJ, Barr IG, Malik Peiris JS, Cowling BJ Biphasic Waning of Hemagglutination Inhibition Antibody Titers After Influenza Vaccination in Children 2022 J Infect Dis. Sep 21;226(6):1022-1026 
PubMed link
doi: 10.1093/infdis/jiac117
Ballou WR, Baylor N, Cueni T, Dzau V, Fukuda K, Garcia PJ, Gupta A, Kadillli E, Kerr L, Larson HJ, Simpson J, Subbarao K, Yadav P The Influenza Imperative: An Urgent Need to Leverage Lessons from COVID-19 to Prepare for a Global Response to Seasonal and Pandemic Influenza 2022 NAM Perspect. Sep 19;2022:10.31478/202209b 
PubMed link
doi: 10.31478/202209b
O'Donnell JS, Isaacs A, Jakob V, Lebas C, Barnes JB, Reading PC, Young PR, Watterson D, Dubois PM, Collin N, Chappell KJ Characterization and comparison of novel adjuvants for a prefusion clamped MERS vaccine 2022 Front Immunol. Sep 2;13:976968 
PubMed link
doi: 10.3389/fimmu.2022.976968
Nazareth J, Pan D, Martin CA, Barr I, Sullivan SG, Stephenson I, Sahota A, Clark TW, Nellums LB, Tang JW, Pareek M Is the UK prepared for seasonal influenza in 2022-23 and beyond? 2022 Lancet Infect Dis. Sep;22(9):1280-1281 
PubMed link
doi: 10.1016/S1473-3099(22)00503-5
Gilbertson B, Subbarao K A new route to vaccines using PROTACs 2022 Nat Biotechnol. Sep;40(9):1328-1329 
PubMed link
doi: 10.1038/s41587-022-01406-y
Audsley JM, Holmes NE, Mordant FL, Douros C, Zufan SE, Nguyen THO, Kedzierski L, Rowntree LC, Hensen L, Subbarao K, Kedzierska K, Nicholson S, Sherry N, Thevarajan I, Tran T, Druce J Temporal differences in culturable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) from the respiratory and gastrointestinal tracts in a patient with moderate coronavirus disease 2019 (COVID-19) 2022 Infect Control Hosp Epidemiol. Sep;43(9):1286-1288 
PubMed link
doi: 10.1017/ice.2021.223
Koszalka P, George A, Dhanasekaran V, Hurt AC, Subbarao K Effect of Baloxavir and Oseltamivir in Combination on Infection with Influenza Viruses with PA/I38T or PA/E23K Substitutions in the Ferret Model 2022 mBio. Aug 30;13(4):e0105622 
PubMed link
doi: 10.1128/mbio.01056-22
Belser JA, Lau EHY, Barclay W, Barr IG, Chen H, Fouchier RAM, Hatta M, Herfst S, Kawaoka Y, Lakdawala SS, Lee LYY, Neumann G, Peiris M, Perez DR, Russell C, Subbarao K, Sutton TC, Webby RJ, Yang H, Yen HL; Working group on the standardization of the ferret model for influenza risk assessment Robustness of the Ferret Model for Influenza Risk Assessment Studies: a Cross-Laboratory Exercise 2022 mBio. Aug 30;13(4):e0117422 
PubMed link
doi: 10.1128/mbio.01174-22
Schwab LSU, Londrigan SL, Brooks AG, Hurt AC, Sahu A, Deng YM, Moselen J, Coch C, Zillinger T, Hartmann G, Reading PC Induction of Interferon-Stimulated Genes Correlates with Reduced Growth of Influenza A Virus in Lungs after RIG-I Agonist Treatment of Ferrets 2022 J Virol. Aug 24;96(16):e0055922 
PubMed link
doi: 10.1128/jvi.00559-22
Bailie CR, Tseng YY, Carolan L, Kirk MD, Nicholson S, Fox A, Sullivan SG Trend in Sensitivity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Serology One Year After Mild and Asymptomatic Coronavirus Disease 2019 (COVID-19): Unpacking Potential Bias in Seroprevalence Studies 2022 Clin Infect Dis. Aug 24;75(1):e357-e360 
PubMed link
doi: 10.1093/cid/ciac020
Ju Y, Lee WS, Pilkington EH, Kelly HG, Li S, Selva KJ, Wragg KM, Subbarao K, Nguyen THO, Rowntree LC, Allen LF, Bond K, Williamson DA, Truong NP, Plebanski M, Kedzierska K, Mahanty S, Chung AW, Caruso F, Wheatley AK, Juno JA, Kent SJ Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine 2022 ACS Nano. Aug 23;16(8):11769-11780 
PubMed link
doi: 10.1021/acsnano.2c04543
Hoa LNM, Sullivan SG, Mai LQ, Khvorov A, Phuong HVM, Hang NLK, Thai PQ, Thanh LT, Carolan L, Anh DD, Duong TN, Bryant JE, van Doorn HR, Wertheim HFL, Horby P, Fox A Influenza A(H1N1)pdm09 But Not A(H3N2) Virus Infection Induces Durable Seroprotection: Results From the Ha Nam Cohort 2022 J Infect Dis Aug 12;226(1):59-69 
PubMed link
doi: 10.1093/infdis/jiaa293
Farrukee R, Gunalan V, Maurer-Stroh S, Reading PC, Hurt AC Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution 2022 J Virol. Aug 10;96(15):e0091822 
PubMed link
doi: 10.1128/jvi.00918-22
Neil JA, Griffith M, Godfrey DI, Purcell DFJ, Deliyannis G, Jackson D, Rockman S, Subbarao K, Nolan T Nonhuman primate models for evaluation of SARS-CoV-2 vaccines 2022 Expert Rev Vaccines. Aug;21(8):1055-1070 
PubMed link
doi: 10.1080/14760584.2022.2071264
Feng S, Enosi Tuipulotu D, Pandey A, Jing W, Shen C, Ngo C, Tessema MB, Li FJ, Fox D, Mathur A, Zhao A, Wang R, Pfeffer K, Degrandi D, Yamamoto M, Reading PC, Burgio G, Man SM Pathogen-selective killing by guanylate-binding proteins as a molecular mechanism leading to inflammasome signaling 2022 Nat Commun. Jul 29;13(1):4395 
PubMed link
doi: 10.1038/s41467-022-32127-0
Price O, Birrell FA, Mifsud EJ, Sullivan SG Epidemiology of repeat influenza infection in Queensland, Australia, 2005-2017 2022 Epidemiol Infect. Jul 18;150:e144 
PubMed link
doi: 10.1017/S0950268822001157
Schwab LSU, Villalón-Letelier F, Tessema MB, Londrigan SL, Brooks AG, Hurt A, Coch C, Zillinger T, Hartmann G, Reading PC Expression of a Functional Mx1 Protein Is Essential for the Ability of RIG-I Agonist Prophylaxis to Provide Potent and Long-Lasting Protection in a Mouse Model of Influenza A Virus Infection 2022 Viruses. Jul 15;14(7):1547 
PubMed link
doi: 10.3390/v14071547
Regan AK, Arah OA, Sullivan SG Performance of diagnostic coding and laboratory testing results to measure COVID-19 during pregnancy and associations with pregnancy outcomes 2022 Paediatr Perinat Epidemiol.Jul;36(4):508-517 
PubMed link
doi: 10.1111/ppe.12863
Tessema MB, Farrukee R, Andoniou CE, Degli-Esposti MA, Oates CV, Barnes JB, Wakim LM, Brooks AG, Londrigan SL, Reading PC Mouse Mx1 Inhibits Herpes Simplex Virus Type 1 Genomic Replication and Late Gene Expression In Vitro and Prevents Lesion Formation in the Mouse Zosteriform Model 2022 J Virol. Jun 22;96(12):e0041922 
PubMed link
doi: 10.1128/jvi.00419-22
Li Y, Wang X, Blau DM, Caballero MT, Feikin DR, Gill CJ, Madhi SA, Omer SB, Simões EAF, Campbell H, Pariente AB, Bardach D, Bassat Q, Casalegno JS, Chakhunashvili G, Crawford N, Danilenko D, Do LAH, Echavarria M, Gentile A, Gordon A, Heikkinen T, Huang QS, Jullien S, Krishnan A, Lopez EL, Markić J, Mira-Iglesias A, Moore HC, Moyes J, Mwananyanda L, Nokes DJ, Noordeen F, Obodai E, Palani N, Romero C, Salimi V, Satav A, Seo E, Shchomak Z, Singleton R, Stolyarov K, Stoszek SK, von Gottberg A, Wurzel D, Yoshida LM, Yung CF, Zar HJ; Respiratory Virus Global Epidemiology Network (includes Barr I), Nair H; RESCEU investigators Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis 2022 Lancet. May 28;399(10340):2047-2064 
PubMed link
doi: 10.1016/S0140-6736(22)00478-0
Eden JS, Sikazwe C, Xie R, Deng YM, Sullivan SG, Michie A, Levy A, Cutmore E, Blyth CC, Britton PN, Crawford N, Dong X, Dwyer DE, Edwards KM, Horsburgh BA, Foley D, Kennedy K, Minney-Smith C, Speers D, Tulloch RL, Holmes EC, Dhanasekaran V, Smith DW, Kok J, Barr IG; Australian RSV study group Off-season RSV epidemics in Australia after easing of COVID-19 restrictions 2022 Nat Commun. May 24;13(1):2884 
PubMed link
doi: 10.1038/s41467-022-30485-3
Koszalka P, Subbarao K, Baz M Preclinical and clinical developments for combination treatment of influenza 2022 PLoS Pathog. May 12;18(5):e1010481 
PubMed link
doi: 10.1371/journal.ppat.1010481
Wille M, Grillo V, Ban de Gouvea Pedroso S, Burgess GW, Crawley A, Dickason C, Hansbro PM, Hoque MA, Horwood PF, Kirkland PD, Kung NY, Lynch SE, Martin S, McArthur M, O'Riley K, Read AJ, Warner S, Hoye BJ, Lisovski S, Leen T, Hurt AC, Butler J, Broz I, Davies KR, Mileto P, Neave MJ, Stevens V, Breed AC, Lam TTY, Holmes EC, Klaassen M, Wong FYK Australia as a global sink for the genetic diversity of avian influenza A virus 2022 PLoS Pathog. May 10;18(5):e1010150 
PubMed link
doi: 10.1371/journal.ppat.1010150
Leung VKY, Wong JY, Barnes R, Kelso J, Milne GJ, Blyth CC, Cowling BJ, Moore HC, Sullivan SG Excess respiratory mortality and hospitalizations associated with influenza in Australia, 2007-2015 2022 Int J Epidemiol. May 9;51(2):458-467 
PubMed link
doi: 10.1093/ije/dyab138
McMenamin ME, Bond HS, Sullivan SG, Cowling BJ Estimation of Relative Vaccine Effectiveness in Influenza: A Systematic Review of Methodology 2022 Epidemiology. May 1;33(3):334-345 
PubMed link
doi: 10.1097/EDE.0000000000001473
Robinson EJ, Gregory J, Mulvenna V, Segal Y, Sullivan SG Effect of Temperature and Rainfall on Sporadic Salmonellosis Notifications in Melbourne, Australia 2000-2019: A Time-Series Analysis 2022 Foodborne Pathog Dis. May;19(5):341-348 
PubMed link
doi: 10.1089/fpd.2021.0093
Wille M, Barr IG Resurgence of avian influenza virus 2022 Science. Apr 29;376(6592):459-460 
PubMed link
doi: 10.1126/science.abo1232
Clarke M, Mathew SM, Giles LC, Pena AS, Barr IG, Richmond PC, Marshall HS A Prospective Study Investigating the Impact of Obesity on the Immune Response to the Quadrivalent Influenza Vaccine in Children and Adolescents 2022 Vaccines (Basel). Apr 29;10(5):699 
PubMed link
doi: 10.3390/vaccines10050699
Messina NL, Germano S, McElroy R, Rudraraju R, Bonnici R, Pittet LF, Neeland MR, Nicholson S, Subbarao K, Curtis N; BRACE trial, de Lima GT Off-target effects of bacillus Calmette-Guérin vaccination on immune responses to SARS-CoV-2: implications for protection against severe COVID-19 2022 Clin Transl Immunology. Apr 22;11(4):e1387 
PubMed link
doi: 10.1002/cti2.1387
Rockman S, Taylor B, McCauley JW, Barr IG, Longstaff R, Bahra R Global Pandemic Preparedness: Optimizing Our Capabilities and the Influenza Experience 2022 Vaccines (Basel). Apr 12;10(4):589 
PubMed link
doi: 10.3390/vaccines10040589
Chang JJ, Gleeson J, Rawlinson D, De Paoli-Iseppi R, Zhou C, Mordant FL, Londrigan SL, Clark MB, Subbarao K, Stinear TP, Coin LJM, Pitt ME Long-Read RNA Sequencing Identifies Polyadenylation Elongation and Differential Transcript Usage of Host Transcripts During SARS-CoV-2 In Vitro Infection 2022 Front Immunol. Apr 6;13:832223 
PubMed link
doi: 10.3389/fimmu.2022.832223
Govorkova EA, Takashita E, Daniels RS, Fujisaki S, Presser LD, Patel MC, Huang W, Lackenby A, Nguyen HT, Pereyaslov D, Rattigan A, Brown SK, Samaan M, Subbarao K, Wong S, Wang D, Webby RJ, Yen HL, Zhang W, Meijer A, Gubareva LV Global update on the susceptibilities of human influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2018-2020 2022 Antiviral Res. Apr;200:105281 
PubMed link
doi: 10.1016/j.antiviral.2022.105281
Brown SK, Tseng YY, Aziz A, Baz M, Barr IG Characterization of influenza B viruses with reduced susceptibility to influenza neuraminidase inhibitors 2022 Antiviral Res. Apr;200:105280 
PubMed link
doi: 10.1016/j.antiviral.2022.105280
Dhanasekaran V, Sullivan S, Edwards KM, Xie R, Khvorov A, Valkenburg SA, Cowling BJ, Barr IG Human seasonal influenza under COVID-19 and the potential consequences of influenza lineage elimination 2022 Nat Commun. Mar 31;13(1):1721 
PubMed link
doi: 10.1038/s41467-022-29402-5
McCafferty C, Lee L, Cai T, Praporski S, Stolper J, Karlaftis V, Attard C, Myint D, Carey LM, Howells DW, Donnan GA, Davis S, Ma H, Crewther S, Nguyen VA, Van Den Helm S, Letunica N, Swaney E, Elliott D, Subbarao K, Ignjatovic V, Monagle P Fibrin clot characteristics and anticoagulant response in a SARS-CoV-2-infected endothelial model 2022 EJHaem. Mar 22;3(2):326-3341 
PubMed link
doi: 10.1002/jha2.407
Subbarao K What influenza activity can we anticipate in 2022? 2022 Med J Aust. Mar 21;216(5):239-241 
PubMed link
doi: 10.5694/mja2.51437
Chen Q, Langenbach S, Li M, Xia YC, Gao X, Gartner MJ, Pharo EA, Williams SM, Todd S, Clarke N, Ranganathan S, Baker ML, Subbarao K, Stewart AG CE2 Expression in Organotypic Human Airway Epithelial Cultures and Airway Biopsies 2022 Front Pharmacol. Mar 11;13:813087 
PubMed link
doi: 10.3389/fphar.2022.813087
Regan AK, Arah OA, Fell DB, Sullivan SG SARS-CoV-2 Infection During Pregnancy and Associated Perinatal Health Outcomes: A National US Cohort Study 2022 J Infect Dis. Mar 2;225(5):759-767 
PubMed link
doi: 10.1093/infdis/jiab626
Toh ZQ, Anderson J, Mazarakis N, Neeland M, Higgins RA, Rautenbacher K, Dohle K, Nguyen J, Overmars I, Donato C, Sarkar S, Clifford V, Daley A, Nicholson S, Mordant FL, Subbarao K, Burgner DP, Curtis N, Bines JE, McNab S, Steer AC, Mulholland K, Tosif S, Crawford NW, Pellicci DG, Do LAH, Licciardi PV Comparison of Seroconversion in Children and Adults With Mild COVID-19 2022 JAMA Netw Open. 2022 Mar 1;5(3):e221313 
PubMed link
doi: 10.1001/jamanetworkopen.2022.1313
Gillies MB, Burgner DP, Ivancic L, Nassar N, Miller JE, Sullivan SG, Todd IMF, Pearson SA, Schaffer AL, Zoega HW Changes in antibiotic prescribing following COVID-19 restrictions: Lessons for post-pandemic antibiotic stewardship 2022 Br J Clin Pharmacol. Mar;88(3):1143-1151 
PubMed link
doi: 10.1111/bcp.15000
Auladell M, Phuong HVM, Mai LTQ, Tseng YY, Carolan L, Wilks S, Thai PQ, Price D, Duong NT, Hang NLK, Thanh LT, Thuong NTH, Huong TTK, Diep NTN, Bich VTN, Khvorov A, Hensen L, Duong TN, Kedzierska K, Anh DD, Wertheim H, Boyd SD, Good-Jacobson KL, Smith D, Barr I, Sullivan S, van Doorn HR, Fox A Influenza virus infection history shapes antibody responses to influenza vaccination 2022 Nat Med. Feb;28(2):363-372 
PubMed link
doi: 10.1038/s41591-022-01690-w
Fox A, Carolan L, Leung V, Phuong HVM, Khvorov A, Auladell M, Tseng YY, Thai PQ, Barr I, Subbarao K, Mai LTQ, van Doorn HR, Sullivan SG Opposing Effects of Prior Infection versus Prior Vaccination on Vaccine Immunogenicity against Influenza A(H3N2) Viruses 2022 FViruses. Feb 25;14(3):470 
PubMed link
doi: 10.3390/v14030470
Liu X, Li X, Chen L, Hsu AC, Asquith KL, Liu C, Laurie K, Barr I, Foster PS, Yang M Proteomic Analysis Reveals a Novel Therapeutic Strategy Using Fludarabine for Steroid-Resistant Asthma Exacerbation 2022 Front Immunol. Feb 25;13:805558 
PubMed link
doi: 10.3389/fimmu.2022.805558
Brusco NK, Alafaci A, Tuckerman J, Frawley H, Pratt J, Daley AJ, Todd AK, Deng YM, Subbarao K, Barr I, Crawford NW The 2018 annual cost burden for children under five years of age hospitalised with respiratory syncytial virus in Australia 2022 Commun Dis Intell (2018). Feb 16;46 
PubMed link
doi: 10.33321/cdi.2022.46.5
Komadina N, Sullivan SG, Leder K, McVernon J Likelihood of prior exposure to circulating influenza viruses resulting in cross-protection by CD8+ T cells against emergent H3N2v swine viruses infecting humans 2022 J Med Virol. Feb;94(2):567-574 
PubMed link
doi: 10.1002/jmv.27299
Bailie CR, Leung VK, Orr E, Singleton E, Kelly C, Buising KL, Cowie BC, Kirk MD, Sullivan SG, Marshall C Performance of hospital-based contact tracing for COVID-19 during Australia's second wave 2022 Infect Dis Health. 2022 Feb;27(1):15-22 
PubMed link
doi: 10.1016/j.idh.2021.09.001
Snape N, Anderson GP, Irving LB, Jarnicki AG, Hurt AC, Collins T, Xi Y, Upham JW Vaccine strain affects seroconversion after influenza vaccination in COPD patients and healthy older people 2022 NPJ Vaccines. Jan 24;7(1):8 
PubMed link
doi: 10.1038/s41541-021-00422-4
Sullivan SG Preparing for out-of-season influenza epidemics when international travel resumes 2022 Med J Aust. Jan 17;216(1):25-26 
PubMed link
doi: 10.5694/mja2.51340
Yang B, Sullivan SG, Du Z, Tsang TK, Cowling BJ Effectiveness of International Travel Controls for Delaying Local Outbreaks of COVID-19 2022 Emerg Infect Dis. Jan;28(1):251-253 
PubMed link
doi: 10.3201/eid2801.211944
Söderlund-Venermo M, Varma A, Guo D, Gladue DP, Poole E, Pujol FH, Pappu H, Romalde JL, Kramer L, Baz M, Venter M, Moore MD, Nevels MM, Ezzikouri S, Vakharia VN, Wilson WC, Malik YS, Shi Z, Abdel-Moneim AS World Society for Virology first international conference: Tackling global virus epidemics 2022 Virology. Jan;566:114-121 
PubMed link
doi: 10.1016/j.virol.2021.11.009
McCauley J, Barr IG, Nolan T, Tsai T, Rockman S, Taylor B The importance of influenza vaccination during the COVID-19 pandemic 2022 Influenza Other Respir Viruses. Jan;16(1):3-6 
PubMed link
doi: 10.1111/irv.12917

Top of Page